Načítá se...
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
BACKGROUND: This is a real-world evidence study that aims to analyze the efficacy, tolerability and safety profile of paritaprevir/ombitasvir/ritonavir and dasabuvir, in patients with renal impairment. METHODS: We conducted an observational prospective study, on 232 patients with chronic kidney dise...
Uloženo v:
| Vydáno v: | BMC Nephrol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966843/ https://ncbi.nlm.nih.gov/pubmed/31948406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-1687-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|